Connecticut AG joins bipartisan coalition evaluating drug makers' role in opioid crisis

By Mark Iandolo | Jun 27, 2017


HARTFORD, Conn. (Legal Newsline) — Connecticut Attorney General George Jepsen announced June 15 that he is working with a bipartisan coalition of attorneys general to determine whether pharmaceutical manufacturers engage in unlawful practices while selling prescription opioids.

The attorneys general seek to determine if the companies play a role in exacerbating the nation’s opioid epidemic.

"The opioid epidemic continues to have a devastating impact in Connecticut," Jepsen said. "Connecticut's policymakers have taken important steps to address the epidemic, and our first responders are doing the truly difficult and critical work of addressing this day in and day out. As attorney general, it is my responsibility to take whatever action is within my authority to help address this crisis, which is why I have joined with my colleagues in announcing our bipartisan, multistate efforts today. It would be irresponsible to predict at this stage whether our efforts will lead to legal action or relief, but Connecticut residents can be assured that we will pursue this investigation fully."

Handling the case for the state are assistant attorneys general Jeremy Pearlman, Ann-Marie DeGraffenreidt and Lorrie Adeyemi, head of the Consumer Protection Department.

Want to get notified whenever we write about Connecticut Attorney General ?

Sign-up Next time we write about Connecticut Attorney General, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.

Organizations in this Story

Connecticut Attorney General

More News

The Record Network